相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice
Ying Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Time-dependent effect of E-coli LPS in spleen DC activation in vivo: Alteration of numbers, expression of co-stimulatory molecules, production of pro-inflammatory cytokines, and presentation of antigens
Li Xu et al.
MOLECULAR IMMUNOLOGY (2017)
Rehmannia glutinosa polysaccharide induces toll-like receptor 4 dependent spleen dendritic cell maturation and anti-cancer immunity
Li Xu et al.
ONCOIMMUNOLOGY (2017)
Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A
Liming Luan et al.
SCIENTIFIC REPORTS (2017)
The combination of checkpoint immunotherapy and targeted therapy in cancer
Niki Karachaliou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
Fumi Sato-Kaneko et al.
JCI INSIGHT (2017)
Modular delivery of CpG-incorporated lipid-DNA nanoparticles for spleen DC activation
Jun-O Jin et al.
BIOMATERIALS (2017)
Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges
Chrisann Kyi et al.
IMMUNOTHERAPY (2016)
Mucosal adjuvants: Opportunities and challenges
Lingbin Zeng
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Advances in Toll-like receptor biology: Modes of activation by diverse stimuli
Clare E. Bryant et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Purified monomeric ligand.MD-2 complexes reveal molecular and structural requirements for activation and antagonism of TLR4 by Gram-negative bacterial endotoxins
Theresa L. Gioannini et al.
IMMUNOLOGIC RESEARCH (2014)
BDCA1-Positive Dendritic Cells (DCs) Represent a Unique Human Myeloid DC Subset That Induces Innate and Adaptive Immune Responses to Staphylococcus aureus Infection
Jun-O Jin et al.
INFECTION AND IMMUNITY (2014)
TLR4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A Differentially Regulate Effector and Memory CD8+ T Cell Differentiation
Weiguo Cui et al.
JOURNAL OF IMMUNOLOGY (2014)
Ascophyllan Purified from Ascophyllum nodosum Induces Th1 and Tc1 Immune Responses by Promoting Dendritic Cell Maturation
Wei Zhang et al.
MARINE DRUGS (2014)
Dendritic cell-targeted vaccines
Lillian Cohn et al.
FRONTIERS IN IMMUNOLOGY (2014)
The role of acetylation in TLR4-mediated innate immune responses
Xiaolan Hu et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Lipopolysaccharide induces IFN-gamma production in human NK cells
Leonid M. Kanevskiy et al.
FRONTIERS IN IMMUNOLOGY (2013)
Recognition of lipopolysaccharide pattern by TLR4 complexes
Beom Seok Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Type 1 Fimbrial Adhesin FimH Elicits an Immune Response That Enhances Cell Adhesion of Escherichia coli
Veronika Tchesnokova et al.
INFECTION AND IMMUNITY (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
Gerty Schreibelt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
FimH Can Directly Activate Human and Murine Natural Killer Cells via TLR4
M. Firoz Mian et al.
MOLECULAR THERAPY (2010)
Adjuvants for cancer vaccines
Thomas W. Dubensky et al.
SEMINARS IN IMMUNOLOGY (2010)
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
B. Romanowski et al.
LANCET (2009)
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex
Beom Seok Park et al.
NATURE (2009)
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
C. R. Casella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Cutting Edge: FimH Adhesin of Type 1 Fimbriae Is a Novel TLR4 Ligand
Karen L. Mossman et al.
JOURNAL OF IMMUNOLOGY (2008)
FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling
Ali A. Ashkar et al.
PLOS PATHOGENS (2008)
New hepatitis B vaccine formulated with an improved adjuvant system
Michael Kundi
EXPERT REVIEW OF VACCINES (2007)
The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture
Petra Schnorrer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance
Elke Cario et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge:: Generation of splenic CD8+ and CD8- dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures
SH Naik et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Helper T cells, dendritic cells and CTL immunity
G Behrens et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Targeting cytotoxic T lymphocytes for cancer immunotherapy
J Maher et al.
BRITISH JOURNAL OF CANCER (2004)
Plasmacytoid dendritic cells: The key to CpG
S Rothenfusser et al.
HUMAN IMMUNOLOGY (2002)
Safety evaluation of monophosphoryl lipid a (MPL): An immunostimulatory adjuvant
P Baldrick et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2002)
Dendritic cell regulation of T(H)1-T(H)2 development
M Moser et al.
NATURE IMMUNOLOGY (2000)
分享论文
